Bio-integrated μBots with overtone ultrawideband magnetoelectric antennas for wireless telemetry

Clinical Snapshot

Key Findings

• P Value: Not reported; no formal inferential statistical testing performed

• Effect Size: 22.6 GHz −10 dB bandwidth — substantially exceeding typical narrow-band implantable antenna bandwidths reported in the literature (commonly <1 GHz for MICS/ISM-band devices); specific comparative effect size not quantified against a defined control

• Primary Outcome: OUWB-ME antennas achieved a −10 dB bandwidth of 22.6 GHz, with overtone operation in the 3–4 GHz range; reproducible transmission windows identified at approximately 3.3 GHz and 3.9 GHz in ex vivo rat and human tissues

• Nnt Or Sensitivity: Not applicable for this device characterisation study; relevant engineering metrics include bandwidth, S-parameter stability under biological loading, and telemetry data fidelity — specific sensitivity/specificity or NNT metrics are not applicable at this preclinical stage

• Confidence Interval: Not reported

Clinical Application

Technically promising but clinically distant. The μBot platform requires in vivo animal implantation studies, chronic biocompatibility assessment, SAR characterisation, miniaturisation to clinically relevant form factors, and regulatory approval before human use. The use of silver nanoparticle inks and iron-gallium alloys introduces materials regulatory complexity. Software-defined radio infrastructure for telemetry readout would require integration with existing clinical monitoring ecosystems. In Australia, any implantable device incorporating novel antenna technology would require TGA evaluation under the Therapeutic Goods Act 1989, with classification likely as a Class III implantable active medical device subject to conformity assessment. The 3.3–3.9 GHz frequency range overlaps with 5G NR n78 band allocations in Australia (ACMA spectrum plan), which may facilitate integration with existing telecommunications infrastructure but also raises electromagnetic compatibility regulatory considerations. The RACGP and relevant specialist colleges (CSANZ, AES) would need to evaluate clinical utility evidence before adoption. PBS listing of any associated monitoring system would require demonstrated clinical benefit in randomised trials. No current Australian clinical guideline addresses this technology. The University of Glasgow-led consortium has no listed Australian institutional partner, though the human tissue component may be relevant to Australian Biobank or tissue ethics frameworks if future collaboration is pursued. Patients requiring implantable or wearable bioelectronic devices for continuous wireless telemetry — including those with implantable neural interfaces, cardiac monitors, closed-loop neuromodulation devices, or continuous glucose monitoring systems. The platform is preclinical and not yet applicable to any patient population.

Abstract

Implantable and wearable devices require antennas that are both miniaturized and efficient, yet conventional designs are constrained by narrow bandwidth and orientation sensitivity. We report overtone ultrawideband magnetoelectric (OUWB-ME) antennas that exploit higher-order acoustic modes in polished silicon substrates to achieve a 22.6-gigahertz -10-decibel bandwidth and overtone capability in the 3- to 4-gigahertz range. Packaged into "μBots," these magnetoelectric heterostructures bonded with silver nanoparticle inks maintain stable operation under biological loading. In vitro assays confirm the biocompatibility of aluminum nitride and the protective role of parylene encapsulation for iron-gallium. Ex vivo rat and human tissues reshape transmission and reflection spectra, with reproducible frequency windows near 3.3 and 3.9 gigahertz. μBots enable real-time audiovisual telemetry using software-defined radios and exhibit compatibility with 7-tesla magnetic resonance imaging. By combining wideband response, robustness to misalignment, and biocompatible packaging, OUWB-ME μBots provide a scalable platform for wireless bio-integrated communication and telemetry.